Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 24 of 24 entries
View as:

TASK-002: Bioequivalence of Bedaquiline 400mg Administered in Crushed Form Compared to Tablet Form in Healthy Male and Female Adults Under Fed Conditions (BDQ Crush Study)

Phase: N/A Priority: Normal
NCT ID: NCT03032367 Org: User:
Start: 11/10/16 End: 01/11/17 Due: 01/11/18

Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa

Phase: N/A Priority: Normal
NCT ID: NCT05539989 Org: User:
Start: 12/31/24 End: 07/31/27 Due: 07/31/28

IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence

Phase: N/A Priority: Normal
NCT ID: NCT02140944 Org: User:
Start: 02/05/15 End: 10/19/22 Due: 10/19/23

Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01728961 Org: User:
Start: 02/29/12 End: 03/31/14 Due: 03/31/15

Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings

Phase: N/A Priority: Normal
NCT ID: NCT04024488 Org: User:
Start: 11/11/23 End: 10/15/25 Due: 10/15/26

IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01232361 Org: User:
Start: 10/08/10 End: 07/31/16 Due: 07/31/17

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00080119 Org: User:
Start: 02/29/04 End: 05/31/09 Due: 05/31/10

IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV

Phase: N/A Priority: Normal
NCT ID: NCT02939131 Org: User:
Start: 03/06/17 End: 01/21/20 Due: 01/21/21

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

Phase: N/A Priority: Normal
NCT ID: NCT01338025 Org: User:
Start: 03/31/11 End: 05/31/13 Due: 05/31/14

IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01061164 Org: User:
Start: 03/31/09 End: 06/30/14 Due: 06/30/15

IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody

Phase: N/A Priority: Normal
NCT ID: NCT01206556 Org: User:
Start: 05/31/10 End: 08/31/13 Due: 08/31/14

IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT00977756 Org: User:
Start: 08/31/02 End: 03/31/14 Due: 03/31/15

Psychiatric Problems in Children and Adolescents Infected With HIV at Birth

Phase: N/A Priority: Normal
NCT ID: NCT00100542 Org: User:
Start: 04/30/05 End: 09/30/06 Due: 09/30/07

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

Phase: N/A Priority: Normal
NCT ID: NCT01484522 Org: User:
Start: 10/31/09 End: 09/30/10 Due: 09/30/11

Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

Phase: N/A Priority: Normal
NCT ID: NCT00028145 Org: User:
Start: 10/31/02 End: 06/30/13 Due: 06/30/14

IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03416790 Org: User:
Start: 02/06/19 End: 03/26/20 Due: 03/26/21

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Phase: N/A Priority: Normal
NCT ID: NCT00719602 Org: User:
Start: 08/31/09 End: 08/31/13 Due: 08/31/14

IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants

Phase: N/A Priority: Normal
NCT ID: NCT02383849 Org: User:
Start: 08/04/15 End: 02/14/20 Due: 02/14/21

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

Phase: N/A Priority: Normal
NCT ID: NCT00307151 Org: User:
Start: 12/31/05 End: 12/31/16 Due: 12/31/17

IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00663234 Org: User:
Start: 08/31/09 End: 12/31/14 Due: 12/31/15

IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites

Phase: N/A Priority: Normal
NCT ID: NCT01240486 Org: User:
Start: 11/30/10 End: 10/31/13 Due: 10/31/14

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

Phase: N/A Priority: Normal
NCT ID: NCT05154513 Org: User:
Start: 02/02/22 End: 11/30/25 Due: 11/30/26

IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women

Phase: N/A Priority: Normal
NCT ID: NCT00955968 Org: User:
Start: 01/01/10 End: 08/31/16 Due: 08/31/17

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT01818258 Org: User:
Start: 10/26/15 End: 09/29/17 Due: 09/29/18